Compare APTV & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APTV | MEDP |
|---|---|---|
| Founded | 2011 | 1992 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 11.9B |
| IPO Year | 2011 | 2016 |
| Metric | APTV | MEDP |
|---|---|---|
| Price | $73.85 | $445.59 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 12 |
| Target Price | $88.80 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 3.8M | 306.6K |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | 0.88 | ★ 4.28 |
| Revenue | ★ $20,398,000,000.00 | N/A |
| Revenue This Year | $7.40 | $13.19 |
| Revenue Next Year | $4.87 | $7.75 |
| P/E Ratio | ★ $77.95 | $105.48 |
| Revenue Growth | ★ 3.47 | N/A |
| 52 Week Low | $51.68 | $293.20 |
| 52 Week High | $88.93 | $628.92 |
| Indicator | APTV | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 75.56 | 53.22 |
| Support Level | $69.38 | $425.57 |
| Resistance Level | $87.98 | $483.30 |
| Average True Range (ATR) | 2.59 | 14.58 |
| MACD | 2.18 | 5.07 |
| Stochastic Oscillator | 98.94 | 70.82 |
Aptiv PLC is an industrial technology company focused on enabling a more automated, electrified and digitalized future. The company's technologies reach from sensor to cloud, including the hardware and software necessary to support automotive and other industries on a global basis. Its Advanced Safety and User Experience segment provides advanced software and services, intelligent sensors and high-performance compute platforms; its Engineered Components Group segment provides connection systems, high-performance interconnects, and cable management and protection solutions; and its Electrical Distribution Systems segment provides low voltage and high voltage power, signal and data distribution.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.